Cape Cod Five Cents Savings Bank Boosts Position in Chemed Co. (NYSE:CHE)

Cape Cod Five Cents Savings Bank increased its stake in Chemed Co. (NYSE:CHE) by 2.6% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,439 shares of the company’s stock after buying an additional 162 shares during the quarter. Cape Cod Five Cents Savings Bank’s holdings in Chemed were worth $3,870,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in CHE. Cetera Advisors LLC purchased a new position in Chemed in the 1st quarter valued at about $267,000. GAMMA Investing LLC grew its stake in Chemed by 34.4% during the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after purchasing an additional 22 shares in the last quarter. CWM LLC increased its holdings in Chemed by 18.5% during the 2nd quarter. CWM LLC now owns 397 shares of the company’s stock worth $215,000 after purchasing an additional 62 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Chemed by 422.9% in the 2nd quarter. SG Americas Securities LLC now owns 7,551 shares of the company’s stock valued at $4,097,000 after purchasing an additional 6,107 shares in the last quarter. Finally, LVW Advisors LLC boosted its stake in shares of Chemed by 8.7% during the 2nd quarter. LVW Advisors LLC now owns 936 shares of the company’s stock valued at $508,000 after buying an additional 75 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Analyst Ratings Changes

CHE has been the subject of a number of research analyst reports. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th. Royal Bank of Canada lowered their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the transaction, the chief executive officer now directly owns 103,735 shares in the company, valued at approximately $62,117,555.35. The trade was a 1.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Spencer S. Lee sold 732 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the sale, the executive vice president now owns 18,287 shares of the company’s stock, valued at $10,526,362.94. The trade was a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,132 shares of company stock valued at $3,003,502. Corporate insiders own 3.32% of the company’s stock.

Chemed Price Performance

Shares of NYSE CHE opened at $552.62 on Monday. Chemed Co. has a 1-year low of $523.33 and a 1-year high of $654.62. The firm has a market capitalization of $8.32 billion, a PE ratio of 27.92, a P/E/G ratio of 2.42 and a beta of 0.46. The business’s fifty day moving average price is $574.95 and its two-hundred day moving average price is $565.03.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the previous year, the firm earned $5.32 earnings per share. Equities research analysts expect that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend was Monday, November 18th. Chemed’s dividend payout ratio is currently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.